InvestorsHub Logo
Followers 12
Posts 532
Boards Moderated 0
Alias Born 02/22/2011

Re: None

Tuesday, 08/31/2021 9:56:18 AM

Tuesday, August 31, 2021 9:56:18 AM

Post# of 458091
I think what is getting forgotten in the discussion of potential drug pricing for Anavex is that this is a publicly traded for-profit organization where the CEO has a fiduciary responsibility to shareholders and must answer to the BOD. It is his responsibility to maximize the long-term profits of the organization while doing so in an ethical and legal manner. The projected profits are what drive the engine to perform additional trials that can positively affect the lives of millions, perhaps billions, of people. Discussions regarding what is fair, or just, or humane pricing are moral discussions and, while to be considered, should not negatively effect the performance of the company to the detriment of the shareholders. That is how a CEO loses his job and class action suits commence. I expect Missling to hold true to these standards. Just imo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News